Potential effects of genetic variations in fusion protein on the virulence of human respiratory syncytial virus - Report - MDSpire

Potential effects of genetic variations in fusion protein on the virulence of human respiratory syncytial virus

  • By

  • Jingjing Song

  • Na Wang

  • Zhen Zhu

  • Naiying Mao

  • Hai Li

  • Jinhua Song

  • Lei Cao

  • Baicheng Xia

  • Min Liao

  • Wuyang Zhu

  • Yan Zhang

  • July 3, 2026

  • 0 min

Share

Impact of Genetic Variants in Fusion Protein on the Pathogenicity of HRSV

Overview

This study evaluates the effects of genetic variations in the fusion protein of human respiratory syncytial virus (HRSV) on viral replication and pathogenicity.

Background

HRSV is a leading cause of acute lower respiratory infections in infants, with significant global morbidity and mortality. Understanding the genetic variations in the HRSV fusion protein is crucial for developing effective vaccines and antiviral therapies.

Data Highlights

StrainPeak Viral Titer DelayPathogenicity
rLong-BJ1903-AF≥ 12 hLess severe than Long-BAC
rLong-SY2103-BF≥ 12 hGreater pathogenicity than rLong-BJ1903-AF

Key Findings

  • Both recombinant HRSV strains showed attenuated replication kinetics compared to the Long-BAC strain.
  • Peak viral titers were delayed by at least 12 hours post-infection for both recombinant strains.
  • In vivo studies indicated that both recombinant viruses caused less severe disease than the Long-BAC strain.
  • rLong-SY2103-BF exhibited greater pathogenicity than rLong-BJ1903-AF, evidenced by slower body weight recovery and higher lung viral loads.
  • Elevated proinflammatory cytokine levels were observed in the rLong-SY2103-BF group.
  • Marked pulmonary pathological alterations were noted in the rLong-SY2103-BF strain.

Clinical Implications

The findings suggest that genetic variations in the HRSV fusion protein can influence viral pathogenicity and replication dynamics. This information may guide future vaccine development and therapeutic strategies targeting HRSV.

Conclusion

The study provides insights into the impact of F protein genetic variations on HRSV pathogenicity.

Related Resources & Content

  1. The Journal of Infectious Diseases, 2023 -- Analysis of Amino Acid Changes in the Fusion Protein of Respiratory Syncytial Virus from Fukushima, Japan, Between 2008 and 2023 and Their Impact on Antibody Response
  2. Frontiers in Immunology, 2026 -- Rational design 2.0: transitioning from static structural biology to computational prioritization and iterative vaccine optimization for RSV
  3. Frontiers in Immunology, 2026 -- Evaluation of a strain Long human respiratory syncytial virus with M2–2 gene deletion in intranasally vaccinated BALB/c mice
  4. CDC -- RSV Vaccine Guidance for Adults
  5. Infection — Human Metapneumovirus (hMPV): A Newly Identified Contributor to Respiratory Infections
  6. RSV Vaccine Guidance for Adults | RSV | CDC
  7. A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses | Nature Microbiology

Original Source(s)

Potential effects of genetic variations in fusion protein on the virulence of human respiratory syncytial virus

  • by Jingjing Song, Na Wang, Zhen Zhu, Naiying Mao, Hai Li, Jinhua Song, Lei Cao, Baicheng Xia, Min Liao, Wuyang Zhu, Yan Zhang

  • July 3, 2026

Related Content

AI-empowered human microbiome research

Single-cell immune landscape of the central nervous system of mice infected with rabies virus

Genetic and molecular approaches for patients with familial hemophagocytic lymphohistiocytosis: a multi-center experience from Mexico